Action Edgewise Therapeutics - EWTX

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

28,25

Prix Achat

28,19

Prix Vente

28,29

Volume échangé

365 926

27,50 Fourchette du Jour 29,40

14,75 Plage de 52 semaines 38,12

Cap du marché

2,675B

Clôture Veille

28,30

Ouverture

28,28

Dernière Transaction

28.2063

Dernière heure de transaction

17:29:59

Volume financier

US$ 10 450 946

VWAP

28,5603

Volume moyen (3 m)

847 074

Actions en circulation

94 688 517

Rendement du Dividende

Ratio Cours sur Bénéfices

-27,07

Bénéfice par action (BPA)

-1,06

Chiffre d'affairess

Bénéfice net

-100,16M

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.edgewisetx.com

Siège social

Wilmington, Delaware, USA

Fondé

Edgewise Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker EWTX. Le dernier cours de clôture d'Edgewise Therapeutics était de US$28,30. Au cours de la dernière année, les actions de Edgewise Therapeutics ont été négociées dans une fourchette de prix de US$ 14,75 à US$ 38,12.

Edgewise Therapeutics compte actuellement 94 688 517 actions en circulation. La capitalisation boursière d'Edgewise Therapeutics est de US$2,68 milliard. Edgewise Therapeutics a un ratio cours/bénéfice (ratio PE) de -27.07.

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development

- Robert Blaustein, M.D., Ph.D. appointed as Chief Development Officer (CDO) - - Behrad Derakhshan, Ph.D. promoted to Chief Operating Officer (COO) - Edgewise Therapeutics, Inc., (Nasdaq: EWTX...

Edgewise Therapeutics Provides Corporate Update and Highlights Priorities for 2025

- Advancing robust clinical pipeline of novel therapeutics for serious muscular dystrophies and cardiac conditions - - Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Monday...

Edgewise Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that Kevin Koch, Ph.D, President and Chief Executive Officer, will present at the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Edgewise Therapeutics Announces Positive Topline Results from the CANYON Phase 2 Trial of Sevasemten in Individuals with Becker Muscular Dystrophy (Becker)

– Trial met primary endpoint of reduction in circulating levels of creatine kinase (CK), a biomarker associated with skeletal muscle damage, in the largest Becker interventional trial to date – –...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	1.68	6.32292058713	26.57	29.68	26	1133678	27.75364734	CS
4	0.21	0.748930099857	28.04	30.3	23.08	971497	26.88712761	CS
12	-5.69	-16.7648791986	33.94	38.12	23.08	847074	30.35494352	CS
26	9.15	47.9057591623	19.1	38.12	14.75	1012334	26.92667461	CS
52	11.76	71.31594906	16.49	38.12	14.75	871332	23.23883582	CS
156	13.79	95.3665283541	14.46	38.12	5.12	483333	17.66510239	CS
260	1.25	4.62962962963	27	40.49	5.12	428479	18.05328538	CS

EWTX - Frequently Asked Questions (FAQ)

What is the current Edgewise Therapeutics share price?

The current share price of Edgewise Therapeutics is US$ 28,25

How many Edgewise Therapeutics shares are in issue?

Edgewise Therapeutics has 94 688 517 shares in issue

What is the market cap of Edgewise Therapeutics?

The market capitalisation of Edgewise Therapeutics is USD 2,68B

What is the 1 year trading range for Edgewise Therapeutics share price?

Edgewise Therapeutics has traded in the range of US$ 14,75 to US$ 38,12 during the past year

What is the PE ratio of Edgewise Therapeutics?

The price to earnings ratio of Edgewise Therapeutics is -27,07

What is the reporting currency for Edgewise Therapeutics?

Edgewise Therapeutics reports financial results in USD

What is the latest annual profit for Edgewise Therapeutics?

The latest annual profit of Edgewise Therapeutics is USD -100,16M

What is the registered address of Edgewise Therapeutics?

The registered address for Edgewise Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Edgewise Therapeutics website address?

The website address for Edgewise Therapeutics is www.edgewisetx.com

Which industry sector does Edgewise Therapeutics operate in?

Edgewise Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
YIBOPlanet Image International Ltd	US$ 9,33 (333,95%)	17,28M
HWHHWH International Inc	US$ 0,711701 (147,38%)	268,92M
JGAurora Mobile Ltd	US$ 12,9408 (115,25%)	23,77M
AKROAkero Therapeutics Inc	US$ 51,75 (97,67%)	9,64M
TOIIWOncology Institute Inc	US$ 0,041 (83,86%)	197,81k
ALLKAllakos Inc	US$ 0,25755 (-78,71%)	25,59M
NXUNXU Inc	US$ 0,3122 (-49,32%)	4,68M
WOKWORK Medical Technology Group Ltd	US$ 2,62 (-45,64%)	600,72k
VERUVeru Inc	US$ 0,672 (-44,46%)	27,92M
ELABPMGC Holdings Inc	US$ 2,025 (-34,68%)	2,86M
NVDANVIDIA Corporation	US$ 120,74 (-15,34%)	317,33M
HWHHWH International Inc	US$ 0,711701 (147,38%)	268,92M
ONCOOnconetix Inc	US$ 0,7017 (46,19%)	168,86M
HOLOMicroCloud Hologram Inc	US$ 1,78 (14,84%)	158,71M
RGTIRigetti Computing Inc	US$ 12,3307 (-6,59%)	80,72M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Edgewise Therapeutics Inc (EWTX) Cours

Edgewise Therapeutics Inc (EWTX)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Edgewise Therapeutics Inc

EWTX Dernières nouvelles

EWTX - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application